Onity Group Valuation

Is 0KAS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0KAS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0KAS ($30.16) is trading above our estimate of fair value ($4.29)

Significantly Below Fair Value: 0KAS is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0KAS?

Key metric: As 0KAS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0KAS. This is calculated by dividing 0KAS's market cap by their current earnings.
What is 0KAS's PE Ratio?
PE Ratio16.8x
EarningsUS$14.50m
Market CapUS$243.61m

Price to Earnings Ratio vs Peers

How does 0KAS's PE Ratio compare to its peers?

The above table shows the PE ratio for 0KAS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average11.3x
MAB1 Mortgage Advice Bureau (Holdings)
33.2x26.4%UK£347.7m
OSB OSB Group
3.7x-3.8%UK£1.5b
NBS Nationwide Building Society
0.9xn/aUK£1.2b
PAG Paragon Banking Group
7.4x0.2%UK£1.5b
0KAS Onity Group
16.8x31.4%US$243.6m

Price-To-Earnings vs Peers: 0KAS is expensive based on its Price-To-Earnings Ratio (16.8x) compared to the peer average (11.1x).


Price to Earnings Ratio vs Industry

How does 0KAS's PE Ratio compare vs other companies in the GB Diversified Financial Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
NBS Nationwide Building Society
0.9xn/aUS$1.52b
No more companies available in this PE range
0KAS 16.8xIndustry Avg. 13.4xNo. of Companies3PE01020304050+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0KAS is expensive based on its Price-To-Earnings Ratio (16.8x) compared to the UK Diversified Financial industry average (13.4x).


Price to Earnings Ratio vs Fair Ratio

What is 0KAS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0KAS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.8x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 0KAS's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0KAS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$30.16
US$45.00
+49.2%
9.1%US$50.00US$40.00n/a3
Nov ’25n/a
US$43.33
0%
10.9%US$50.00US$40.00n/a3
Oct ’25US$30.43
US$43.33
+42.4%
10.9%US$50.00US$40.00n/a3
Sep ’25US$29.91
US$41.67
+39.3%
15.0%US$50.00US$35.00n/a3
Aug ’25n/a
US$41.00
0%
17.0%US$50.00US$33.00n/a3
Jul ’25US$23.28
US$40.67
+74.7%
18.1%US$50.00US$32.00n/a3
Jun ’25n/a
US$40.67
0%
18.1%US$50.00US$32.00n/a3
May ’25n/a
US$39.33
0%
22.9%US$50.00US$28.00n/a3
Apr ’25US$26.99
US$40.00
+48.2%
20.4%US$50.00US$30.00n/a3
Mar ’25n/a
US$40.00
0%
20.4%US$50.00US$30.00n/a3
Feb ’25US$27.72
US$40.00
+44.3%
20.4%US$50.00US$30.00n/a3
Jan ’25n/a
US$40.00
0%
20.4%US$50.00US$30.00n/a3
Dec ’24n/a
US$40.00
0%
20.4%US$50.00US$30.00n/a3
Nov ’24n/a
US$40.00
0%
20.4%US$50.00US$30.00n/a3
Oct ’24n/a
US$41.67
0%
15.0%US$50.00US$35.00US$30.433
Sep ’24n/a
US$41.67
0%
15.0%US$50.00US$35.00US$29.913
Aug ’24n/a
US$41.67
0%
15.0%US$50.00US$35.00n/a3
Jul ’24n/a
US$41.67
0%
15.0%US$50.00US$35.00US$23.283
Jun ’24US$26.05
US$41.67
+59.9%
15.0%US$50.00US$35.00n/a3
May ’24n/a
US$41.67
0%
15.0%US$50.00US$35.00n/a3
Apr ’24US$26.76
US$41.67
+55.7%
15.0%US$50.00US$35.00US$26.993
Mar ’24US$32.20
US$41.67
+29.4%
15.0%US$50.00US$35.00n/a3
Feb ’24n/a
US$43.00
0%
14.3%US$50.00US$35.00US$27.723
Jan ’24n/a
US$43.00
0%
14.3%US$50.00US$35.00n/a3
Dec ’23n/a
US$43.00
0%
14.3%US$50.00US$35.00n/a3
Nov ’23US$30.14
US$40.33
+33.8%
17.0%US$50.00US$35.00n/a3

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies